Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

ClinicalTrials.gov ID: NCT04530123

Public ClinicalTrials.gov record NCT04530123. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose-Ranging Study to Evaluate the Efficacy and Safety of TAK-101 for the Prevention of Gluten-Specific T Cell Activation in Subjects With Celiac Disease on a Gluten-Free Diet

Study identification

NCT ID
NCT04530123
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Takeda
Industry
Enrollment
102 participants

Conditions and interventions

Conditions

Interventions

  • Placebo Drug
  • TAK-101 Drug
  • Gluten Dietary Supplement

Drug · Dietary Supplement

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 22, 2022
Primary completion
Dec 8, 2025
Completion
Jan 7, 2026
Last update posted
Mar 31, 2026

2022 – 2026

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
One of a Kind Clinical Research Center LLC Scottsdale Arizona 85258
Gastroenterology and Liver Institute Escondido California 92025
Cadena Care Institute, Inc. Poway California 92064
Asthma and Allergy Associates, PC Colorado Springs Colorado 80907
GCP Clinical Research, LLC Tampa Florida 33609
Agile Clinical Research Trials Atlanta Georgia 30328
Lemah Creek Clinical Research Burr Ridge Illinois 60527
Gastroenterology Associates, PA Rockford Illinois 61107
Rockford Gastroenterology Associates, Ltd. Rockford Illinois 61107
Berkshire Medical Center New Albany Indiana 47150
Gastroenterology Health Partners, PLLC New Albany Indiana 47150
Boston Specialists Boston Massachusetts 02111
Massachusetts General Hospital Boston Massachusetts 02114
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Berkshire Medical Center, Inc. Pittsfield Massachusetts 01201
Clinical Research Institute of Michigan, LLC Chesterfield Michigan 48048
Wellness Clinical Research Chesterfield Michigan 48048
Mayo Clinic - Rochester Rochester Minnesota 55905
Albuquerque Clinical Trials, Inc. Albuquerque New Mexico 87102
Basil Clinical Inwood New York 11096
Mount Sinai New York New York 10029
Columbia University Medical Center. New York Presbyterian Hospital New York New York 10032
East Carolina Gastroenterology, PA Jacksonville North Carolina 28546
GI Alliance-Rhode Island Providence Rhode Island 02904
Amel Med LLC Georgetown Texas 78628
Care Access Research - Salt Lake City Ogden Utah 84403

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04530123, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 31, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04530123 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →